Elsevier

Cellular Immunology

Volume 182, Issue 2, 15 December 1997, Pages 125-136
Cellular Immunology

Regular Article
CD30-Regulated Apoptosis in Murine CD8 T Cells after Cessation of TCR Signals

https://doi.org/10.1006/cimm.1997.1228Get rights and content
Under a Creative Commons license
open archive

Abstract

A variety of culture systems have been developed to study mechanisms of activation-induced cell death in peripheral T lymphocytes either during the initial period after exposure to an activating stimulus or following repeated stimulation of activated T cells. In this study we describe a new culture model for the analysis of apoptosis after withdrawal of TCR signals from activated T cells. T cells activated by anti-CD3 antibodies for 48 h and then further cultured in the presence of IL-2 but absence of continued CD3/TCR stimulation underwent dramatic cell death approximately 4 days following removal of the TCR stimulus. Apoptotic cells generated in this protocol, unlike those produced by hyperstimulation, retained substantial levels of degraded DNA following fixation, consistent with death in the G0/G1phase of the cell cycle. This “agonist withdrawal” cell death occurred largely within the CD8 T cell subset, with CD4 cells showing lower levels of apoptosis. This form of cell death did not appear to be the result of IL-2 exhaustion, since repeated addition of IL-2 during the culture period did not significantly alter the number of apoptotic cells. Apoptosis induced by agonist withdrawal was not blocked by Fas antigen fusion protein or by anti-TNFα-neutralizing antibodies, suggesting a mechanism independent of Fas/FasL and TNFα/TNF-R interactions. Cell death was, however, significantly inhibited by treatment with a CD30 fusion protein. CD30 was found to be transiently expressed on CD8 T cells immediately prior to death, with lower expression on CD4 cells, while CD30 ligand was found to be expressed most strongly by CD4 T cells. These results suggest a role for CD30 in regulating the onset of apoptosis in CD8 T cells after interruption of CD3/TCR.

Cited by (0)

This work was supported by NIA Grants AG03978, AG09801, and AG08808 (to Dr. Miller) and NIH Grants CA59531, CA39201, and CA57904 (to Dr. Podack). Dr. Telford was supported in part by NIH Training Grants AI07413 and AG00114.